Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,962
Closed -$226K 474
2023
Q2
$226K Sell
2,962
-762
-20% -$62.3K 0.02% 422
2023
Q1
$301K Sell
3,724
-678
-15% -$54.6K 0.03% 403
2022
Q4
$329K Sell
4,402
-867
-16% -$61.7K 0.04% 376
2022
Q3
$357K Sell
5,269
-4,873
-48% -$338K 0.04% 342
2022
Q2
$724K Buy
10,142
+682
+7% +$50.6K 0.09% 251
2022
Q1
$727K Buy
9,460
+2,477
+35% +$178K 0.08% 255
2021
Q4
$493K Buy
+6,983
New +$513K 0.06% 300

Other funds holding HOLX

Ascent Group's HOLX Position: Q3 2023 in Review

Ascent Group sold out of Hologic (HOLX) in Q3 2023, closing a stake of 2,962 shares — an estimated $226K sold.

Ascent Group first reported a position in HOLX in Q4 2021 and held it in 7 quarters. The position peaked at $727K in Q1 2022. 692 funds tracked by Wall St. Rank hold HOLX as of Q3 2023.

  • Ascent Group reported no remaining Hologic position as of Q3 2023 after selling out during the quarter.
  • Ascent Group sold 2,962 Hologic shares in Q3 2023, an estimated $226K.
  • Ascent Group first reported a position in Hologic in Q4 2021 and held it in 7 quarters.
  • Ascent Group's Hologic position peaked at $727K in Q1 2022.
  • 692 funds tracked by Wall St. Rank held Hologic as of Q3 2023.

Based on Ascent Group's 13F filing for Q3 2023, filed 14 Nov 2023.